Usefulness of intraplatelet melatonin levels to predict angiographic no-reflow after primary percutaneous coronary intervention in patients with st-segment elevation myocardial infarction

American Journal of Cardiology

Volumn 106, Issue 11, 2010, Pages 1540-1544

  Dominguez Rodriguez, Alberto ^a   Abreu Gonzalez, Pedro ^b   Jimenez Sosa, Alejandro ^a   Avanzas, Pablo ^c   Bosa Ojeda, Francisco ^a   Kaski, Juan Carlos ^d  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^d ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MELATONIN;

ADULT; ANGIOGRAPHY; ARTICLE; CELL LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NO REFLOW PHENOMENON; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBOCYTE; THROMBOCYTE RICH PLASMA;

ANGIOPLASTY, BALLOON, CORONARY; BIOLOGICAL MARKERS; BLOOD PLATELETS; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MELATONIN; MIDDLE AGED; MYOCARDIAL INFARCTION; NO-REFLOW PHENOMENON; ODDS RATIO; PROGNOSIS; TREATMENT OUTCOME;

EID: 78649319176     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.07.030     Document Type: Article

References (29)

1. A. Dominguez-Rodriguez, P. Abreu-Gonzalez, and R.J. Reiter Clinical aspects of melatonin in the acute coronary syndrome Curr Vasc Pharmacol 7 2009 367 373
2. A. Dominguez-Rodriguez, P. Abreu-Gonzalez, M. Garcia-Gonzalez, and R.J. Reiter Prognostic value of nocturnal melatonin levels as a novel marker in patients with ST-segment elevation myocardial infarction Am J Cardiol 97 2006 1162 1164
3. Y.M. Lee, H.R. Chen, G. Hsiao, J.R. Sheu, J.J. Wang, and M.H. Yen Protective effects of melatonin on myocardial ischemia/reperfusion injury in vivo J Pineal Res 33 2002 72 80
4. C. Rodriguez, J.C. Mayo, R.M. Sainz, I. Antoln, F. Herrera, V. Martn, and R.J. Reiter Regulation of antioxidant enzymes: a significant role for melatonin J Pineal Res 36 2004 1 9
5. L. Di Bella, and L. Gualano Key aspects of melatonin physiology: thirty years of research Neuro Endocrinol Lett 27 2006 425 432
6. A.L. Morera, and P. Abreu Existence of melatonin in human platelets J Pineal Res 39 2005 432 433
7. M.I. Vacas, M.M. Del Zar, M. Martinuzzo, and D.P. Cardinali Binding sites for [3H]-melatonin in human platelets J Pineal Res 13 1992 60 65
8. L.I. Kornblihtt, L. Finocchiaro, and F.C. Molinas Inhibitory effect of melatonin on platelet activation induced by collagen and arachidonic acid J Pineal Res 14 1993 184 191
9. C. Martinez-Campa, A. Gonzalez, M.D. Mediavilla, C. Alonso-Gonzalez, V. Alvarez-Garcia, E.J. Sanchez-Barcelo, and S. Cos Melatonin inhibits aromatase promoter expression by regulating cyclooxygenases expression and activity in breast cancer cells Br J Cancer 101 2009 1613 1619
10. S. Silber, P. Albertsson, F.F. Avils, P.G. Camici, A. Colombo, C. Hamm, E. Jørgensen, J. Marco, J.E. Nordrehaug, W. Ruzyllo, P. Urban, G.W. Stone, W. Wijns Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology Guidelines for percutaneous coronary interventions The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology Eur Heart J 26 2005 804 847
11. TIMI Study Group The Thrombolysis In Myocardial Infarction (TIMI) trial: phase 1 findings N Engl J Med 312 1985 932 936
12. C.M. Gibson, S.A. Murphy, D.A. Morrow, J.M. Aroesty, R.J. Gibbons, S.G. Gourlay, H.V. Barron, R.P. Giugliano, E.M. Antman, and E. Braunwald Angiographic perfusion score: an angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction Am Heart J 148 2004 336 340
13. R. Schroder Prognostic impact of early ST-segment resolution in acute ST-elevation myocardial infarction Circulation 110 2004 e506 e510
14. G. Niccoli, S. Giubilato, E. Russo, C. Spaziani, A. Leo, I. Porto, A.M. Leone, F. Burzotta, S. Riondino, F. Pulcinelli, L.M. Biasucci, and F. Crea Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention Eur Heart J 29 2008 1843 1850
15. P. Peduzzi, J. Concato, E. Kemper, T.R. Holford, and A.R. Feinstein A simulation study of the number of events per variable in logistic regression analysis J Clin Epidemiol 49 1996 1373 1379
16. Y. Xu, Y. Huo, M.C. Toufektsian, S.I. Ramos, Y. Ma, A.D. Tejani, B.A. French, and Z. Yang Activated platelets contribute importantly to myocardial reperfusion injury Am J Physiol Heart Circ Physiol 290 2006 H692 H699
17. E.J. Topol, and J.S. Yadav Recognition of the importance of embolization in atherosclerotic vascular disease Circulation 101 2000 570 580
18. B. Chaitman, and B. Lim No reflow and the quest to achieve optimal perfusion during the acute phase of myocardial infarction J Am Coll Cardiol 44 2004 313 315
19. S.H. Rezkalla, and R.A. Kloner Coronary no-reflow phenomenon: from the experimental laboratory to the cardiac catheterization laboratory Catheter Cardiovasc Interv 72 2008 950 957
20. C. Ekmekcioglu, T. Thalhammer, S. Humpeler, M.R. Mehrabi, H.D. Glogar, T. Hlzenbein, O. Markovic, V.J. Leibetseder, G. Strauss-Blasche, and W. Marktl The melatonin receptor subtype MT2 is present in the human cardiovascular system J Pineal Res 35 2003 40 44
21. M. Martinuzzo, M.M. Del Zar, D.P. Cardinali, L.O. Carreras, and M.I. Vacas Melatonin effect on arachidonic acid metabolism to cyclooxygenase derivatives in human platelets J Pineal Res 11 1991 111 115
22. M.I. Vacas, M.M. Del Zar, M. Martinuzzo, C. Falcon, L.O. Carreras, and D.P. Cardinali Inhibition of human platelet aggregation and thromboxane B2 production by melatonin Correlation with plasma melatonin levels J Pineal Res 11 1991 135 139
23. P.C. Redondo, G.M. Salido, J.A. Rosado, and J.A. Pariente Effect of hydrogen peroxide on Ca2+ mobilisation in human platelets through sulphydryl oxidation dependent and independent mechanisms Biochem Pharmacol 67 2004 491 502
24. N. Alexandru, I. Jardn, D. Popov, M. Simionescu, J. Garca-Estao, G.M. Salido, and J.A. Rosado Effect of homocysteine on calcium mobilization and platelet function in type 2 diabetes mellitus J Cell Mol Med 12 2008 2015 2026
25. A. Sener, D. Ozsavci, O. Bingol-Ozakpinar, O. Cevik, G. Yanikkaya-Demirel, and T. Yardimci Oxidized-LDL and Fe3+/ascorbic acid-induced oxidative modifications and phosphatidylserine exposure in human platelets are reduced by melatonin Folia Biol (Praha) 55 2009 45 52
26. A. Dominguez-Rodriguez, P. Abreu-Gonzalez, M.J. Garcia-Gonzalez, S. Samimi-Fard, R.J. Reiter, and J.C. Kaski Association of ischemia-modified albumin and melatonin in patients with ST-elevation myocardial infarction Atherosclerosis 199 2008 73 78
27. A. Dominguez-Rodriguez, P. Abreu-Gonzalez, M.J. Garcia-Gonzalez, J.C. Kaski, R.J. Reiter, and A. Jimenez-Sosa A unicenter, randomized, double-blind, parallel-group, placebo-controlled study of Melatonin as an Adjunct in patients with acute myocaRdial Infarction undergoing primary Angioplasty The Melatonin Adjunct in the acute myocaRdial Infarction treated with Angioplasty (MARIA) trial: study design and rationale Contemp Clin Trials 28 2007 532 539
28. A.W. van't Hof, A. Liem, H. Suryapranata, J.C. Hoorntje, M.J. de Boer, F. Zijlstra Zwolle Myocardial Infarction Study Group Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade Circulation 97 1998 2302 2306 (Pubitemid 28280383)
29. G. Niccoli, G.A. Lanza, S. Shaw, E. Romagnoli, D. Gioia, F. Burzotta, C. Trani, M.A. Mazzari, R. Mongiardo, M. De Vita, A.G. Rebuzzi, T.F. Lscher, and F. Crea Endothelin-1 and acute myocardial infarction: a no-reflow mediator after successful percutaneous myocardial revascularization Eur Heart J 27 2006 1793 1798